Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
08/2010
08/05/2010US20100197798 Abuse-resistant amphetamine prodrugs
08/05/2010US20100197795 Transdermal compositions
08/05/2010US20100197790 Container for pharmaceutical use for the quantitative release of a single dose for oral administration of t3 and t4 thyroid hormones in solution
08/05/2010US20100197779 Phytoestrogenic isoflavone compositions, their preparation and use thereof for protection against and treatment of radiation injury
08/05/2010US20100197751 Compositions of pegylated soluble tumor necrosis factor receptors and methods of preparing
08/05/2010US20100197722 Treatment for basal cell carcinoma
08/05/2010US20100197641 Formulation for lipophilic agents
08/05/2010US20100197637 Method of Treatment Using Bisphosphonic Acid
08/05/2010US20100196989 Alpha-Fetoprotein Immu31 Antibodies and Fusion Proteins and Methods of Use Thereof
08/05/2010US20100196513 Colon cleansing compositions and methods
08/05/2010US20100196507 Treatment of Wounds and Compositions Employed
08/05/2010US20100196490 Compositions and methods of delivery of pharmacological agents
08/05/2010US20100196488 Pharmaceutical Formulation
08/05/2010US20100196486 Methods for producing aripiprazole suspension and freeze-dried formulation
08/05/2010US20100196478 Protein matrix materials, devices and methods of making and using thereof
08/05/2010US20100196477 Dry Mouldable drug formulation
08/05/2010US20100196458 Modified cytokines for use in cancer therapy
08/05/2010US20100196454 Dressing formulations to prevent and reduce scarring
08/05/2010US20100196447 Silk biomaterials and methods of use thereof
08/05/2010US20100196438 Methods including medical devices having a surface including a biologically active agent therein
08/05/2010US20100196437 Medical devices having a surface including a biologically active agent therein
08/05/2010US20100196435 Materials and methods for delivering compositions to selected tissues
08/05/2010US20100196418 UNIVERSAL CARRIER FOR TARGETING MOLECULES TO Gb3 RECEPTOR EXPRESSING CELLS
08/05/2010US20100196360 Neutrokine-alpha and neutrokine-alpha splice variant
08/05/2010US20100196322 Polymer for tissue engineering applications and drug delivery
08/05/2010US20100196292 Hydrophylic silicone elastomers in cosmetics
08/05/2010CA2751236A1 Finely pulverized pharmaceutical composition
08/05/2010CA2751068A1 Anti-cancer protein-platinum conjugates
08/05/2010CA2751010A1 Antibiotic peptides
08/05/2010CA2750758A1 Treatment of psoriasis
08/05/2010CA2750617A1 Oral film-form base and oral film-form preparation
08/05/2010CA2750269A1 Crystalline insulin-conjugates
08/05/2010CA2750245A1 Polynucleotide aptamer-based cross-linked materials and uses thereof
08/05/2010CA2750146A1 Matte skin finish compositions
08/05/2010CA2749966A1 Il-1 binding proteins
08/05/2010CA2749698A1 Resuscitation fluid
08/05/2010CA2749533A1 Solid oral formulations of a pyridopyrimidinone
08/05/2010CA2749397A1 Pharmaceutical compositions comprising phosphate-binding polymer
08/05/2010CA2749126A1 Oligomer-phenothiazine conjugates
08/04/2010EP2213747A1 Method for producing membrane protein
08/04/2010EP2213743A1 Albumin fusion proteins
08/04/2010EP2213742A1 Chimeric antigens for breaking host tolerance to foreign antigens
08/04/2010EP2213735A1 Peptide imparting antibody-binding ability to liposome and liposome modified with the same
08/04/2010EP2213316A1 Iodine-coated expandable device
08/04/2010EP2213308A1 Eyedrop comprising agar
08/04/2010EP2213307A1 Injectable depot formulations
08/04/2010EP2213306A1 Method of producing granules containing material of natural origin such as chinese orthodox medicine extract, crude drug extract, natural material extract or mixture thereof and method of producing tablets from the granules
08/04/2010EP2213305A1 Method for producing granulated matter
08/04/2010EP2213304A1 Granule, tablet, and their production methods
08/04/2010EP2213284A1 Preparation for application to body surface and preparation holding sheet for application to body surface
08/04/2010EP2213281A1 Pharmaceutical composition comprising N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine hydrochloride
08/04/2010EP2212279A1 Cationic lipids
08/04/2010EP2211908A2 Conjugates of anti-rg-1 antibodies
08/04/2010EP2211907A1 Carboxymethylcellulose polyethylene glycol compositions for medical uses
08/04/2010EP2211904A2 Cd19 binding agents and uses thereof
08/04/2010EP2211839A1 Long acting injectable formulations
08/04/2010EP2211838A2 Bowel purgative and uses thereof
08/04/2010EP2211836A2 Taste-masked orally disintegrating tablets of memantine hydrochloride
08/04/2010EP2211834A2 Method for preparing a vaccine composition comprising at least one antigen and at least one adjuvant
08/04/2010EP2062598B1 Gel type enteric nutrient
08/04/2010EP1819362B1 Topical nepafenac formulations
08/04/2010EP1608344B1 Oral formulations of cladribine
08/04/2010EP1531862B1 Stabilized liquid anti-rsv antibody formulations
08/04/2010EP1032675B1 Attaching substances to micro-organisms
08/04/2010CN201537287U Thymosin alpha 1 preparation
08/04/2010CN201537252U Medicinal moisture-proof granule
08/04/2010CN1809377B Orally dosed pharmaceutical compositions comprising a delivery agent in micronized form
08/04/2010CN101796191A complexes of rna and cationic peptides for transfection and for immunostimulation
08/04/2010CN101795713A conjugate purification
08/04/2010CN101795712A Pharmaceutical compound
08/04/2010CN101795711A chemical linkers and cleavable substrates and conjugates thereof
08/04/2010CN101795710A Oral nicotine formulation buffered with amino acid
08/04/2010CN101795694A Injection, injection solution and injection kit preparation
08/04/2010CN101795672A Liposome formulations of boronic acid compounds
08/04/2010CN101795671A Liposome compositions for in vivo administration of boronic acid compounds
08/04/2010CN101795670A Liquid formulation of G-CSF
08/04/2010CN101795669A Compositions for delivering a drug
08/04/2010CN101795558A Body fluid expanders comprising N-substituted aminosulfonic acid buffers
08/04/2010CN101792752A Metarginase and recombination expression method and use thereof
08/04/2010CN101792525A Conjugated biological molecules and their preparation
08/04/2010CN101792524A Glycosyl polyethers, preparation method thereof and use thereof
08/04/2010CN101792516A Biodegradable polymer vesicles and preparation and application thereof
08/04/2010CN101792484A Anthracycline derivative of polypeptide containing tyrosine-isoleucine-glycine-serine-arginine
08/04/2010CN101791412A Acyclovir-chitosan-stearic acid grafting, synthetic method and application thereof
08/04/2010CN101791411A Preparation and application of amphiphilic polysaccharide conjugate and medicinal compositions thereof
08/04/2010CN101791410A Preparation and application of conjugate of anti-infective medicament and polysaccharide and medicinal composition thereof
08/04/2010CN101791409A peptide vectors
08/04/2010CN101791408A Cationic polymer gene vector having low cytotoxicity and high transfection efficiency, preparation method and use thereof
08/04/2010CN101791407A Gentamicin sulfate wrapped in polylactic acid/nano-hydroxyapatite composite microspheres and preparation method thereof
08/04/2010CN101791399A Water-containing liquid allergic reaction bacterin preparation for mouth mucosa drug administration
08/04/2010CN101791396A Controlled release compositions for interferon based on PEGT/PBT block copolymers
08/04/2010CN101791323A Ginkgo biloba extract dripping pill and preparation method thereof
08/04/2010CN101791315A Compound monoammonium glycyrrhizinate S pharmaceutical composition and method for preparing high-capacity injection
08/04/2010CN101791311A Pharmaceutical composition with short pressure-reducing function
08/04/2010CN101791310A Vinpocetine medicine composition and preparation method thereof
08/04/2010CN101791309A Oral solid preparation containing clopidogrel hydrogen sulfate
08/04/2010CN101791302A Medicinal composition containing sodium ferulate and preparation method thereof
08/04/2010CN101791299A Method for preparing potassium citrate sustained-release tablets
08/04/2010CN101791298A Colon delivery tablet by using pectin / corn protein as coating
08/04/2010CN101791296A Orlistat tablets and preparation method thereof
1 ... 476 477 478 479 480 481 482 483 484 485 486 487 488 489 490 491 492 493 494 495 496 ... 1712